KZR · Kezar Life Sciences, Inc.
$7.29
+0.00 (+0.00%)
At close · May 11
Market Cap
$53.86M
Shares
7.39M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Christopher Kirk | CEO | $927,300 |
| Marc Belsky | CFO | $915,043 |
| Mark Schiller | President and CEO | $868,378 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John Fowler | CEO | $4,830,882 |
| Christopher Kirk | CEO | $2,602,155 |
| Noreen Roth Henig | Chief Medical Officer | $2,198,505 |
| Marc Belsky | CFO | $2,006,319 |
| Nick Mordwinkin | Chief Business Officer | $1,763,679 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John Fowler | CEO | $6,193,511 |
| Noreen Roth Henig | Chief Medical Officer | $2,621,344 |
| Christopher Kirk | CEO | $2,470,432 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John Fowler | CEO | $5,645,417 |
| Noreen Roth Henig | Chief Medical Officer | $1,811,616 |
| Christopher Kirk | President and Chief Scientific Officer | $1,685,890 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Noreen Roth Henig | Chief Medical Officer | $1,459,001 |
| John Fowler | CEO | $1,265,683 |
| Christopher Kirk | President and Chief Scientific Officer | $880,099 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| John Fowler | CEO | $3,532,024 |
| Niti Goel | Former Chief Medical Officer | $2,128,210 |
| Christopher Kirk | President and Chief Scientific Officer | $1,942,334 |
| Marc Belsky | CFO | $1,595,872 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| John Fowler | CEO | $1,800,543 |
| Niti Goel | Former Chief Medical Officer | $1,201,310 |
| Christopher Kirk | President and Chief Scientific Officer | $962,353 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Hearne | Chief Financial Officer | Appointed | 2026-05-11 |
| Stephen Robertson | Chief Legal Officer, Corporate Secretary and Chief Compliance Officer | Appointed | 2026-05-11 |
| Ryan Cole | Chief Operating Officer | Appointed | 2026-05-11 |
| Kevin Tang | Chief Executive Officer | Appointed | 2026-05-11 |
| Kevin Tang | sole director | Appointed | 2026-05-11 |
| Courtney Wallace | board of directors | Resigned | 2026-05-11 |
| Micki Klearman, M.D. | board of directors | Resigned | 2026-05-11 |
| Michael Kauffman, M.D., Ph.D. | board of directors | Resigned | 2026-05-11 |
| Graham Cooper | board of directors | Resigned | 2026-05-11 |
| Elizabeth Garner, M.D. | board of directors | Resigned | 2026-05-11 |
| Franklin Berger | board of directors | Resigned | 2026-05-11 |
| John Fowler | board of directors | Resigned | 2026-05-11 |